Dyne: H2 2024 Muscle Disease Data Could Boost Value (NASDAQ:DYN)

Published on 5 Mar 2024 on Seeking Alpha

Dyne Therapeutics, Inc. results from DYNE-101 for the treatment of patients with Myotonic Dystrophy...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 12 NASDAQ Stocks with Biggest Upside Potential According to...

Insider Monkey · via Yahoo Finance 22 Nov 2024

We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now. In this article, we are g...

Insider Monkey · via Yahoo Finance 7 Oct 2024

Why Is Dyne Therapeutics Stock Soaring On Monday? Monday, Dyne Therapeutics Inc (NASDAQ:DYN) rele...

Benzinga via Yahoo Finance 23 May 2024

Shares of Landos Biopharma, Inc. LABP rose sharply during Monday’s session following acquisition...

Benzinga 25 Mar 2024

Stocks that are trading heavily or have substantial price changes on Monday: United Airlines, Dyn...

Washington Post 25 Mar 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday. Shares of ...

Benzinga 25 Mar 2024

Muscle disease company Dyne Therapeutics (DYN) said on Monday that John Cox has been appointed pr...

Seeking Alpha 25 Mar 2024

Investing.com 25 Mar 2024

Dyne Therapeutics, Inc. results from DYNE-101 for the treatment of patients with Myotonic Dystrop...

Seeking Alpha 5 Mar 2024

Joshua Brumm, CEO & President of Dyne Therapeutics Inc (NASDAQ:DYN), has sold 100,000 shares of t...

GuruFocus.com via Yahoo Finance 2 Mar 2024